Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

被引：1
|
作者：
Bar-Or, Amit
Grove, Richard A.
Tolson, Jerry M.
Derosier, Frederick J.
Lopez, Monica C.
Kavanagh, Sarah T.
Miller, Aaron E.
机构：
来源：
NEUROLOGY | 2019年 / 92卷 / 11期
关键词：
D O I：
10.1212/WNL.0000000000007085
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：543 / 543
页数：1
相关论文
共 50 条
  • [1] Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis The MIRROR study
    Bar-Or, Amit
    Grove, Richard A.
    Austin, Daren J.
    Tolson, Jerry M.
    VanMeter, Susan A.
    Lewis, Eric W.
    Derosier, Frederick J.
    Lopez, Monica C.
    Kavanagh, Sarah T.
    Miller, Aaron E.
    Sorensen, Per S.
    NEUROLOGY, 2018, 90 (20) : E1805 - E1814
  • [2] Reader response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
    Kearney, Hugh
    NEUROLOGY, 2019, 92 (11) : 542 - 543
  • [3] Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study
    Lewis, Ariane
    Galetta, Steven
    NEUROLOGY, 2019, 92 (11) : 542 - 542
  • [4] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [5] Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis The MIRROR study (vol 90, e1805, 2018)
    NEUROLOGY, 2018, 91 (11) : 538 - 538
  • [6] Follow-up data from the Mirror study: a dose-ranging study of subcutaneous ofatumumab in subjects with relapsing-remitting multiple sclerosis
    Sorenson, P. S.
    Kavanagh, S. T.
    Austin, D. J.
    Grove, R. A.
    Lopez, M. C.
    Tolson, J. M.
    Van Meter, S. A.
    Bar-Or, A.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 88 - 88
  • [7] Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis A phase 2 study
    Sorensen, Per S.
    Lisby, Steen
    Grove, Richard
    Derosier, Frederick
    Shackelford, Steve
    Havrdova, Eva
    Drulovic, Jelena
    Filippi, Massimo
    NEUROLOGY, 2014, 82 (07) : 573 - 581
  • [8] Predicting response to fingolimod in patients with relapsing-remitting multiple sclerosis
    Giuliani, M.
    Prosperini, L.
    Fanelli, F.
    Hirsch, M. N.
    De Angelis, F.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 306 - 306
  • [9] Relapsing-remitting multiple sclerosis
    Flores, A
    Ochoa, E
    Zamora, S
    Barrientos, UN
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 214 (1-2) : 110 - 110
  • [10] Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
    Río, J
    Nos, C
    Tintoré, M
    Téllez, N
    Galán, I
    Pelayo, R
    Comabella, M
    Montalban, X
    ANNALS OF NEUROLOGY, 2006, 59 (02) : 344 - 352
12345